Padcev 30 mg (Enfortumab Vedotin POWDER FOR SOLUTION) 30 MG

Padcev (Enfortumab Vedotin) 30 mg is a powder for solution used in intravenous therapy. This medication is designed to target specific proteins in the body, potentially offering therapeutic benefits for certain conditions.

Strength

30 MG

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Padcev (Enfortumab Vedotin) is a type of targeted therapy used in the treatment of specific types of cancer. It works by targeting proteins on the surface of cancer cells, which may help to slow or stop the growth of these cells. This medication is typically used in combination with other treatments as part of a comprehensive cancer care plan.

Side Effects

Common effects of Padcev (Enfortumab Vedotin) may include fatigue, nausea, and peripheral neuropathy. Some individuals may also experience skin reactions or changes in their blood cell counts. These effects can vary widely from person to person and may not affect everyone who uses this medication.

Precautions & Warnings

Padcev (Enfortumab Vedotin) should be handled with care and administered under the supervision of a healthcare professional. It is important to follow all safety guidelines and storage instructions provided by the manufacturer. This medication may not be suitable for everyone, and potential risks should be discussed with a healthcare provider.

Avoid Interactions

Padcev (Enfortumab Vedotin) may interact with other medications, including those that affect the immune system or blood cell production. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Padcev (Enfortumab Vedotin) is used in the treatment of certain types of cancer, targeting specific proteins on cancer cells.

Padcev (Enfortumab Vedotin) is administered intravenously as a powder for solution.

Common side effects may include fatigue, nausea, peripheral neuropathy, and skin reactions.

Potential interactions with other medications should be discussed with a healthcare provider.

Individuals with certain medical conditions or allergies should consult a healthcare provider before using Padcev (Enfortumab Vedotin).

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.